United States & GSK plc

United States: The United States is involved in escalating tensions with Iran, which has impacted oil prices and contributed to inflation concerns, leading to potential interest rate hikes by the United States — Federal Reserve.

GSK plc: GSK plc's shares rose after it agreed to acquire GSK plc for $10.6 billion, indicating positive market reception to its strategic acquisition.

United States: The studies discussed involve patients and practices within the United States>>> and address a significant health concern for American women.

GSK plc: GSK plc>>>'s drug Avodart is mentioned in a comparison study where GLP-1s were associated with lower rates of prostate cancer diagnoses.

United States: The United States is the country where the study was conducted, focusing on the Zoster vaccine vaccine available in its market and utilizing Medicare data from its nursing facilities.

GSK plc: GSK plc is the maker of the Zoster vaccine vaccine. The study, although funded by GSK plc, was independently designed and conducted, and its positive findings regarding dementia risk reduction could enhance the company's reputation and vaccine sales.

GSK plc: GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.

GSK plc: GSK plc, a hepatitis B vaccine maker, defended its products as safe, and its shares finished 0.3% lower.

GSK plc: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.